Advertisement

Reactions Weekly

, Volume 1734, Issue 1, pp 197–197 | Cite as

Durvalumab/mogamulizumab/tremelimumab

Various toxicities: 17 case reports
Case report

Reference

  1. Welborn M, et al. Retrospective Chart Review of Cutaneous Adverse Events Associated with Tremelimumab in 17 Patients. American Journal of Clinical Dermatology 19: 899-905, No. 6, Dec 2018. Available from: URL: http://doi.org/10.1007/s40257-018-0376-3 - USA

Copyright information

© Springer Nature Switzerland AG 2019

Personalised recommendations